期刊文献+

基于胸腰椎压缩骨折患者报告的临床结局评价量表的初步构建和统计分析 被引量:2

Preliminary construction and statistical analysis of efficacy evaluation based on thoracolumbar vertebrae compression fractures patients reported outcomes
下载PDF
导出
摘要 目的建立基于胸腰椎压缩骨折患者报告的临床结局(PRO)评价量表,从患者报告的角度为胸腰椎压缩骨折临床疗效评价提供一个新的方法。方法采用文献资料查询、专家咨询等方法,参考患者日常就诊时的主诉,结合国内外临床常用量表的条目,进一步完善量表并形成PRO初始量表。结果初步形成一个具有4个域体系(躯体症状、躯体感觉、心理状态和社会交往)、16个条目的量表。该量表总克朗巴赫系数α(Cronbach'sα)为0.878。折半信度(Split-Cronbach'sα)分析为0.783。量表KMO统计量为0.831,通过Bartlett检验,各变量间信息的重叠程度较高(2=1 921.243,P<0.01),适合做因子分析。结论该量表具有较高的信度、效度,可作为胸腰椎压缩骨折患者报告的临床疗效评价的初级量表。 Objective It is to compile the efficacy evaluation scale based on patient reported outcomes (PRO) of thoraco- lumbar vertebrae compression fractures patients to provide a new way of evaluation of clinical effect from the viewpoint of pa- tients" report. Methods Literature consulting, talking with patients, and consulting to experts were adopted to establish domain system containing physical symptoms, physical sensation, mental status and social communication and then set up the items. Results A questionnaire which contained 4 localized system( body syndrome, body feeling, mental state and social interaction) and 16 items was established. The total Cronbach's Alpha of the questionnaire was 0. 878. By Split - Cronbach Alpha analysis, the Split - Cronbachg Alpha value was 0. 783. The KMO( Kaiser - Meyer - Olkin Measure of Sampling Adequacy) value was 0. 831, by Bartlett test (P 〈0. 001, x2 = 1 921. 243 ) , indicating that it was rationale to make factor analysis because of the high overlapness among the variables, and that the questionnaire had a high validity statistically. Conclusion The very PRO Scale was high in reliability and validity and was usable primarily for the clinical efficacy evaluation based on (PRO) in patients with thoracolumbar vertebrae compression fractures.
出处 《现代中西医结合杂志》 CAS 2013年第4期356-359,共4页 Modern Journal of Integrated Traditional Chinese and Western Medicine
关键词 胸腰椎压缩骨折 患者报告的临床结局 量表 临床疗效评价 统计学分析 thoracoIumbar vertebrae compression fractures patient reported outcomes questionnaire clinical efficacy e-valuation statistical analysis
  • 相关文献

参考文献9

二级参考文献39

  • 1赵利,刘凤斌,梁国辉,方积乾,林丽珠,陈金泉.中华生存质量量表的理论结构模型研制探讨[J].中国临床康复,2004,8(16):3132-3134. 被引量:50
  • 2吴焕林,赵益业,邹旭,罗文杰,邓铁涛.冠心病的五脏相关论治[J].湖北中医杂志,2005,27(8):18-20. 被引量:20
  • 3Pincus T, Bergman MJ, Yazici Y, et al. An index of only patient-reported outcome measures, routine assessment of patient index data 3 (RAPID3), in two abatacept clinical trials: similar results to disease activity score (DAS28) and other RAPID indices that include physician-reported measures[J]. Rheumatology, 2008,47 (3) : 345 - 349.
  • 4PincusT, Segurado OG. Most visits of mostpatients with rheumatoid arthritis to most rheumatologists do not include a formal quantitative joint count[J]. Ann Rheum Dis, 2006, 65(6) :820- 822.
  • 5Pincus T, Amara I, Segurado OG, et al. Relative efficiencies of physician/assessor global estimates and patient questionnaire measures are similar to or greater than joint counts to distinguish adalimumab from control treatments in rheumatoid arthritis clinical trials[J]. J Rheumatol, 2008, 35(2) :201 - 205.
  • 6U. S. Department of Health and Human Services FDA Center for Drug Evaluation and Research, FDA Center for Biologics Evaluation and Research, FDA Center for Devices and Radiological Health. Guidance for inductory; Patient-reported outcome measures: use in medical product development to support labeling claims:draft guidance[J]. Health Qual Life Outcome, 2006, (4) : 79.
  • 7Kirwan J, Heiberg T, Hewlett S,et al. Outcomes from the Patient Perspective Workshop at OMERACT 6 [ J ]. J Rheumatol, 2003,30 (4) : 868 - 872.
  • 8Kirwan JR, Hewlett SE, Heiberg T, et al. Incorporating the patient perspective into outcome assessment in rheumatoid arthritis progress at OMERACT 7[J]. J Rheumatol, 2005,32 (11 ) : 2250 - 2256.
  • 9FDA. Guidance for industry-patient-reported outcome measures:use in medical product development to support labeling claims,draft guidance. Health Qua] Life outcomes, 2006,27(9):4-70.
  • 10Leung Kwok-fai,Liu Feng-bin,ZhaoLi,et al.Development and Validation of the Chinese Qulaity of life instrument [EB/OL].Helath and Quality of life outcomes,[2005-03-26]http//www.hqlo.com/ content/3/1/6.

共引文献88

同被引文献26

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部